EP300 and type 2 diabetes mellitus: Importantly, the decreased p300 protein levels in beta-cells of human subjects with T2D, confronted with the data obtained from human data sets showing similar p300 mRNA levels in beta-cells/islets from T2D and non-diabetic subjects, further supports a post-transcriptional regulation and degradation of p300.